To determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses listed in the SOW as well as other rapidly emerging viruses that utilize the same…
Ended Awarded Last action
- Contract number
- 75N93022F00001
- Awardee
-
Utah State University UEI SPE2YDWHDYU4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $40,250
Award facts
- Opportunity
-
- B09 Solicitation number
- Contract value 87% obligated
-
- $40,250.00 Current, with exercised options
- $46,001.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Logan, UT 84322, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $13,000 | |
| Original award | $27,250 |
About this award
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $46,001 firm fixed price delivery order to Utah State University under the In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity contract vehicle. The delivery order requires USU to determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses listed in the statement of work, as well as other rapidly emerging viruses that can be tested using the same assay methodology. This work supports NIH/NIAID's broader mission to conduct and support research on infectious and immune-mediated diseases. No set aside designation was specified.
Description
To determine the antiviral inhibitory effect and cytotoxicity of experimental antiviral compounds against viruses listed in the SOW as well as other rapidly emerging viruses that utilize the same assay methodology.
Quick answers
Who was awarded contract 75N93022F00001?
75N93022F00001 was awarded to Utah State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 10, 2021.
How much is contract 75N93022F00001 worth?
The government has obligated $40,250 on 75N93022F00001. Its potential value, with all options, is $46,001.
Is contract 75N93022F00001 an order under another contract?
Yes. 75N93022F00001 is a delivery order under 75N93019D00021, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93022F00001 competed?
The extent of competition for 75N93022F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award